Publikasjoner

​​​Bøker


Løvås K, Husebye E​
Endokrinologi - en medisinsk lærebok
1. utgave. Gyldendal 2013. 248 sider
2. utgave 2017
 
Omtaler: 

Anmeldelse Utposten 7-2013
Anmeldelse i Tidsskrift for den Norske
Legeforening 6-2014

Løvås, K
1. utgave. Stenersens forlag 2014. 254 sider


 

Artikler

2016:

Simunkova K, Jovanovic N, Rostrup E, Methlie P, Øksnes M, Nilsen RM, Hennø H, Tilseth M, Godang K, Kovac A, Løvås K, Husebye ES. Effect of a pre-exercise hydrocortisone dose on short-term physical performance in female patients with primary adrenal failure. Eur J Endocrinol 174, 97-105, 2016.

Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA, Torpy DJ. Diagnosis and treatment of primary adrenal insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metabol 101, 364-389, 201

Nils Landegren N, Sharon D, Freyhult E, Hallgren Ã…, Eriksson D, Edqvist PH, Bensing S, Wahlberg J, Nelson LM, Gustafsson J, Husebye ES, Anderson MS, Snyder M, Kämpe O. Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1. Sci Rep. 2016 Feb 1;6:20104.

Hetemäki I, Jarva H, Kluger N, Baldauf HM, Laakso S, Bratland E, Husebye ES, Kisand K, Ranki A, Peterson P, Arstila TP. Anticommensal Responses Are Associated with Regulatory T Cell Defect in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Patients. J Immunol. 196, 2955-64, 2016.

Edvardsen K, Hellesen A, Husebye ES, Bratland E. Analysis of cellular and humoral immune responses against cytomegalovirus in patients with autoimmune Addison's disease. J Transl Med. 14, 68, 2016.

Landegren N, Pourmousa Lindberg M, Skov J, Hallgren Ã…, Eriksson D, Lisberg Toft-Bertelsen T, MacAulay N, Hagforsen E, Räisänen-Sokolowski A, Saha H, Nilsson T, Nordmark G, Ohlsson S, Gustafsson J, Husebye ES, Larsson E, Anderson MS, Perheentupa J, Rorsman F, Fenton RA, Kämpe O. Autoantibodies Targeting a Collecting Duct-Specific Water Channel in Tubulointerstitial Nephritis. J Am Soc Nephrol. 2016 Oct;27(10):3220-3228.

Bensing S, Hulting AL, Husebye ES, Kämpe O, Løvås K. MANAGEMENT OF ENDOCRINE DISEASE: Epidemiology, Quality of Life and Complications of Primary Adrenal Insufficiency: a review. Eur J Endocrinol.175, R107-116, 2016.

Astor MC, Løvås K, Debowska A, Eriksen EF, Evang JA, Fossum C, Fougner KJ, Holte SE, Lima K, Moe RB, Myhre AG, Kemp EH, Nedrebø¸ BG, Svartberg J, Husebye ES. Epidemiology and health related quality of life in hypoparathyroidism in Norway. J Clin Endocrinol Metab. 101, 345-354, 2016

Simunkova K, Husebye ES. Adrenal Insufficiency Therapy: How to Keep the Balance between Good Quality of Life and Low Risk for Long-Term Side Effects. Front Horm Res. 46, 196-210, 2016.

Bruserud Ø, Oftedal BE, Landegren N, Erichsen MM, Bratland E, Lima K, Jørgensen AP, Myhre AG, Svartberg J, Fougner KJ, Bakke Å, Nedrebø BG, Mella B, Breivik L, Viken MK, Knappskog PM, Marthinussen MC, Løvås K, Kämpe O, Wolff AB, Husebye ES. A Longitudinal Follow-up of Autoimmune Polyendocrine Syndrome Type 1. J Clin Endocrinol Metab. 101, 2975-83, 2016.

Meyer S, Woodward M, Hertel C, Vlaicu P, Haque Y, Kärner J, Macagno A, Onuoha SC, Fishman D, Peterson H, Metsküla K, Uibo R, Jäntti K, Hokynar K, Wolff AS; APECED patient collaborative, Krohn K, Ranki A, Peterson P, Kisand K, Hayday A. AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies. Cell 166, 582-95, 2016.

 

 

2015: ​​

 

Mitchell AL, Bøe Wolff A, MacArthur K, Weaver JU, Vaidya B, Swedish Addison Registry Study Group, Erichsen MM, Darlay R, Husebye ES, Cordell HJ, Pearce SH. Linkage analysis in autoimmune Addison’s disease: NFATC1 as a potential novel susceptibility locus.  PLoS One. 2015 Jun 4;10(6):e0123550

Fichna M, Zurawek M, Bratland E, Husebye ES, Kasperlik-Zaluska A, Czarnocka B, Januszkiewicz-Lewandowska D,
Nowak J. Interleukin-2 and subunit alpha of its soluble receptor in autoimmune Addison’s disease - an association study and expression analysis. Autoimmunity. 2015 Mar;48(2):100-7.

Bruserud Ø, Husebye ES. A man in his 30s with diabetes and vitiligo. No. 8, 5. mai 2015 Tidsskr Nor Legeforen 2015
135:763-6

Oftedal BE, Hellesen A, Erichsen MM, Bratland E, Vardi A, Perheentupa J, Kemp EH, Fiskerstrand T, Viken MK, Weetman AP, Fleishman SJ, Banka S, Newman WG, Sewell WA, Sozaeva LS, Zayats T, Haugarvoll K, Orlova EM, Haavik J, Johansson S, Knappskog PM, Løvås K, Wolff AS, Abramson J, Husebye ES. Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases. Immunity. 2015 Jun 16;42(6):1185-96

Björnsdottir S, Øksnes M, Isaksson M, Methlie P, Nilsen RM, Hustad S, Kämpe O, Hulting AL, Husebye ES, Løvås K,
Nyström T, Bensing S. Circadian hormone profiles and insulin sensitivity in patients with Addison’s disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy. Clin Endocrinol (Oxf). 2015 Jul;83(1):28-35

Edvardsen K, Bjåsøy T, Hellesen A, Breivik L, Bakke M, Husebye ES, Bratland E. Peripheral blood cells from patients with autoimmune Addison’s disease poorly respond to interferons in vitro, despite elevated serum levels of interferon-inducible chemokines. J Interferon Cytokine Res. 2015 Oct;35(10):759-70.

Falorni A, Bini V, Betterle C, Brozzetti A, Castaño L, Fichna M, Kämpe O, Mellgren G, Peterson P, Chen S, Rönnelid
J, Seissler J, Tiberti C, Uibo R, Yu L, Lernmark A , Husebye
ES. Determination of 21-hydroxylase autoantibodies:inter-laboratory concordance in the Euradrenal InternationalSerum Exchange Program. Clin Chem Lab Med. 2015 Oct;53(11):1761-70.

Astor MC, Løvås K, Wolff AS, Nedrebø B, Bratland E, Steen-Johnsen J, Husebye ES. Hypomagnesemia and functional hypoparathyroidism due to novel mutations in the Mg-channel TRPM6. Endocr Connect 2015 vol. 4 no. 4 215-222

 

Quinkler M, Dahlqvist P, Husebye ES, Kämpe O. A European Emergency Card for adrenal insufficiency can save lives. Eur J Intern Med. 2015 Jan;26(1):75-6.

2014:​​​

Björnsdottir S, Øksnes M, Isaksson M, Methlie P, Nilsen RM, Hustad S, Kämpe O, Hulting AL, Husebye ES, Løvås K, Nyström T, Bensing S. Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy.                                                                                                                                   Clin Endocrinol (Oxf). 2014 Nov 17.

Fichna M, Zurawek M, Bratland E, Husebye ES, Kasperlik-Zaluska A, Czarnocka B, Januszkiewicz-Lewandowska D, Nowak J. Interleukin-2 and subunit alpha of its soluble receptor in autoimmune Addison's disease - An association study and expression analysis.​                                                                                                                                   Autoimmunity. 2014 Oct 27:1-8. 

Wolff AS, Kärner J, Owe JF, Oftedal BE, Gilhus NE, Erichsen MM, Kämoe O, Meager A, Peterson P, Kisand K, Willcox N, Husebye ES. Clinical and serologic parallels to APS-I in patients with thymomas and autoantigen transcripts in their tumors.                              J Immunol. 2014 Oct 15;193(8):3880-90.

Dawoodji A, Chen JL, Shepherd D, Dalin F, Tarlton A, Alimohammadi M, Penna-Martinez M, Meyer G, Mitchell AL, Gan EH, Bratland E, Bensing S, Husebye ES, Pearce SH, Badenhoop K, Kämpe O, Cerundolo V.​ High Frequency of Cytolytic 21-Hydroxylase-Specific CD8+ T Cells in Autoimmune Addison's Disease Patients.​ J Immunol. 2014 Sep 1;193(5):2118-26. doi: 10.4049/jimmunol.1400056. Epub 2014 Jul 25.

Short AD, Catchpole B, Boag AM, Kennedy LJ, ​Massey J, Rothwell S, Henthorn PS, Littman MP, Husebye E, Ollier B. Putative candidate genes for canine hypoadrenocorticism (Addison's disease) in multiple dog breeds. Vet Rec. 2014 Nov 1;175(17):430

Breivik L, Oftedal BE, Bøe Wolff AS, Bratland E, Orlova EM, Husebye ES. A novel cell-based assay for measuring neutralizing autoantibodies against type I interferons in patients with autoimmune polyendocrine syndrome type 1. ​ Clin Immunol. 2014 Jul;153(1):220-7. doi: 10.1016/j.clim.2014.04.013. Epub 2014 May 2.

Hellesen A, Edvardsen K, Breivik L, Husebye ES, Bratland E. The effect of types I and III interferons on adrenocortical cells and its possible implications for autoimmune Addison's disease.  Clin Exp Immunol. 2014 Jun;176(3):351-62. doi: 10.1111/cei.12291.

Bjanesoy TE, Andreassen BK, Bratland E, Reiner A, Islam S, Husebye ES, Bakke M. Altered DNA methylation profile in Norwegian patients with Autoimmune Addison's Disease. ​Mol Immunol. 2014 Jun;59(2):208-16. doi: 10.1016/j.molimm.2014.02.018. Epub 2014 Mar 22.

Øksnes M, Björnsdottir S, Isaksson M, Methlie P, Carlsen S, Nilsen RM, Broman JE, Triebner K, Kämpe O, Hulting AL, Bensing S, Husebye ES, Løvås K. Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison's disease: a randomized clinical trial. ​ J Clin Endocrinol Metab. 2014 May;99(5):1665-74. doi: 10.1210/jc.2013-4253. Epub 2014 Feb 11.

Brønstad I, Breivik L, Methlie P, Wolff AS, Bratland E, Nermoen I, Løvås K, Husebye ES. 

Functional studies of novel CYP21A2 mutations detected in Norwegian patients with congenital adrenal hyperplasia.​ ​ Endocr Connect. 2014 Apr 15;3(2):67-74. doi: 10.1530/EC-14-0032. Print 2014.

Hegvik TA, Husebye ES, Haavik J. Autoantibodies targeting neurotransmitter biosynthetic enzymes in attention-deficit/hyperactivity disorder (ADHD).  Eur Child Adolesc Psychiatry. 2014 Feb;23(2):115-7. doi: 10.1007/s00787-013-0429-3. Epub 2013 May 28. No abstract available. 

Husebye ES, Allolio B, Arlt W, Badenhoop K, Bensing S, Betterle C, Falorni A, Gan EH, Hulting AL, Kasperlik-Zaluska A, Kämpe O, Løvås K, Meyer G, Pearce SH. Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. ​J Intern Med. 2014 Feb;275(2):104-15. doi: 10.1111/joim.12162. Epub 2013 Dec 16. Review.

Mitchell AL, Macarthur KD, Gan EH, Baggott LE, Wolff AS, Skinningsrud B, Platt H, Short A, Lobell A, Kämpe O, Bensing S, Betterle C, Kasperlik-Zaluska A, Zurawek M, Fichna M, Kockum I, Nordling Eriksson G, Ekwall O, Wahlberg J, Dahlqvist P, Hulting AL, Penna-Martinez M, Meyer G, Kahles H, Badenhoop K, Hahner S, Quinkler M, Falorni A, Phipps-Green A, Merriman TR, Ollier W, Cordell HJ, Undlien D, Czarnocka B, Husebye E, Pearce SH. Association of autoimmune Addison's disease with alleles of STAT4 and GATA3 in European cohorts.​ PLoS One. 2014 Mar 10;9(3):e88991. doi: 10.1371/journal.pone.0088991. eCollection 2014.​

 

2013:

 

Wolff AS, Sarkadi AK, Maródi L, Kärner J, Orlova E, Oftedal BE, Kisand K, Oláh E, Meloni A, Myhre AG, Husebye ES, Motaghedi R, Perheentupa J, Peterson P, Willcox N, Meager A.​ Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood. ​ J Clin Immunol. 2013 Nov;33(8):1341-8. doi: 10.1007/s10875-013-9938-6. Epub 2013 Oct 26.

Short AD, Boag A, Catchpole B, Kennedy LJ, Massey J, Rothwell S, Husebye E, Ollier B. A candidate gene analysis of canine hypoadrenocorticism in 3 dog breeds. ​ J Hered.​ ​2013 Nov-Dec;104(6):807-20. doi: 10.1093/jhered/est051. Epub 2013 Aug 31.​

   Shum AK, Alimohammadi M, Tan CL, Cheng MH, Metzger TC, Law CS, Lwin W, Perheentupa J, Bour-Jordan H, Carel JC, Husebye ES, De Luca F, Janson C, Sargur R, Dubois N, Kajosaari M, Wolters PJ, Chapman HA, Kämpe O, Anderson MS. BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease.  ​Sci Transl Med. 2013 Oct 9;5(206):206ra139. doi: 10.1126/scitranslmed.3006998.

Methlie P, Hustad SS, Kellmann R, Almås B, Erichsen MM, Husebye E, Løvås K.
Multisteroid LC-MS/MS assay for glucocorticoids and androgens, and its application in Addison's Disease.
Endocr Connect. 2013 Jun 14. [Epub ahead of print]

Hegvik TA, Husebye ES, Haavik J. Autoantibodies targeting neurotransmitter biosynthetic enzymes in attention-deficit/hyperactivity disorder (ADHD). ​ Eur Child Adolesc Psychiatry. 2013 May 28 [Epub ahead of print]

Massey J, Boag A, Short AD, Scholey RA, Henthorn PS, Littman MP, Husebye E, Catchpole B, Pedersen N, Mellersh CS, Ollier WE, Kennedy LJ. MHC class II association study in eight breeds of dog with hypoadrenocorticism. ​
Immunogenetics. 2013 Apr;65(4):291-7. doi10.1007/s00251-013-0680-2.

Kärner J, Meager A, Laan M, Maslovskaja J, Pihlap M, Remm A, Juronen E, Wolff AS, Husebye ES, Podkrajšek KT, Bratanic N, Battelino T, Willcox N, Peterson P, Kisand K. 
Anti-cytokine autoantibodies suggest pathogenetic links with autoimmune regulator deficiency in humans and mice. Clin Exp Immunol. 2013 Mar;171(3):263-72. doi: 10.1111/cei.12024.

Methlie P, Dankel S, Myhra T, Christensen BR, Gjerde J, Fadnes D, Våge V, L Vås K, Mellgren G. Changes in adipose glucocorticoid metabolism before and after bariatric surgery assessed by direct hormone measurements. 
Obesity (Silver Spring). 2013 Mar 20. doi: 10.1002/oby.20449. [Epub ahead of print]

Horn MA, Erichsen MM, Wolff AS, Månsson JE, Husebye ES, Tallaksen CM, Skjeldal OH. 
Screening for X-linked adrenoleukodystrophy among adult males with Addison's disease. 
Clin Endocrinol (Oxf). 2013 Jan 24. doi: 10.1111/cen.12159. [Epub ahead of print] 

Bratland E, Hellesen A, Husebye ES. Induction of CXCL10 chemokine in adrenocortical cells by stimulation through toll-like receptor 3.  Mol Cell Endocrinol. 365, 75-83, 2013

2012:

Bratland E, Magitta NF, Bøe Wolff AS, Ekern T, Knappskog PM, Kämpe O, Haavik J, Husebye ES. Autoantibodies against aromatic amino acid hydroxylases in patients with autoimmune polyendocrine syndrome type 1 target multiple antigenic determinants and reveal regulatory regions crucial for enzymatic activity. 
Immunobiology. 2012 Oct 26. doi:pii: S0171-2985(12)00516-5. 10.1016/j.imbio.2012.10.006. [Epub
ahead of print]

Husebye ES, Erichsen MM, Myhre AG, Bratke H, Jørgensen AP, Dahlqvist P, Løvås K.
Nytt steroidkort ved binyrebarksvikt. ​
Tidsskr Nor Laegeforen. 2012 okt 02;132(18):2043-2044.

Hapnes L, Willcox N, Oftedal BE, Owe JF, Gilhus NE, Meager A, Husebye ES, Wolff AS.
Radioligand-binding assay reveals distinct autoantibody preferences for type I interferons in APS I and myasthenia gravis subgroups. 
J Clin Immunol, 32, 230-7, 2012.

Nermoen I, Brønstad I, Fougner KJ, Svartberg J, Oksnes M, Husebye ES, Løvås K.
Genetic, anthropometric and metabolic features of adult Norwegian patients with 21-hydroxylase deficiency. 
Eur J Endocrinol, 167, 507-16, 2012.

Meloni A, Willcox N, Meager A, Atzeni M, Wolff AS, Husebye ES, Furcas M, Rosatelli MC, Cao A, Congia M. Autoimmune Polyendocrine Syndrome Type 1: An Extensive Longitudinal Study in Sardinian Patients. 
J Clin Endocrinol Metab. 97, 1114-1124, 2012.

Øksnes M, Bensing S, Hulting AL, Kämpe O, Hackemann A, Meyer G, Badenhoop K, Betterle C, Parolo A, Giordano R, Falorni A, Papierska L, Jeske W, Kasperlik-Zaluska AA, Chatterjee VK, Husebye ES, Løvås K. Quality of Life in European Patients with Addison's Disease: Validity of the Disease-Specific Questionnaire AddiQoL. 
J Clin Endocrinol Metab, 97, 568-76, 2012.

2011:

Nermoen I, Rørvik J, Holmedal SH, Hykkerud DL, Fougner KJ, Svartberg J, Husebye ES, Løvås K. High frequency of adrenal myelolipomas and testicular adrenal rest tumours in adult Norwegian patients with classical congenital adrenal hyperplasia because of 21-hydroxylase deficiency.                                                                                                 Clin Endocrinol (Oxf). 2011 Dec;75(6):753-9. 


Hapnes L, Willcox N, Oftedal BE, Owe JF, Gilhus NE, Meager A, Husebye ES, Wolff AS. Radioligand-Binding Assay Reveals Distinct Autoantibody Preferences for Type I Interferons in APS I and Myasthenia Gravis Subgroups.   ​                                             J Clin Immunol. 2011 Nov 30. [Epub ahead of print]

Skinningsrud B, Lie BA, Lavant E, Carlson JA, Erlich H, Akselsen HE, Gervin K, Wolff AB, Erichsen MM, Løvås K, Husebye ES, Undlien DE. Multiple loci in the HLA complex are associated with Addison's disease. J Clin Endocrinol Metab. 2011 Oct;96(10)

Oftedal BE, Kämpe O, Meager A, Ahlgren KM, Lobell A, Husebye ES, Wolff AS. Measuring autoantibodies against IL-17F and IL-22 in autoimmune polyendocrine syndrome type I by radioligand binding assay using fusion proteins.​                         Scand J Immunol. 2011 Sep;74(3):327-33

Brønstad I, Wolff AS, Løvås K, Knappskog PM, Husebye ES. Genome-wide copy number variation (CNV) in patients with autoimmune Addison's disease.
BMC Med Genet. 2011 Aug 18;12:111

Bratland E, Husebye ES. Cellular immunity and immunopathology in autoimmune Addison's disease.
Mol Cell Endocrinol. 2011 Apr 10;336(1-2):180-90. Epub 2010 Dec 15. Review.

Smith CJ, Oscarson M, Rönnblom L, Alimohammadi M, Perheentupa J, Husebye ES, Gustafsson J, Nordmark G, Meloni A, Crock PA, Kämpe O, Bensing S.
TSGA10 - A target for autoantibodies in autoimmune polyendocrine syndrome type 1 and systemic lupus erythematosus.​
Scand J Immunol. 2011 Feb;73(2):147-53.

Husebye ES, Kämpe O. Autoimmune polyendocrine syndrome type I – Man.
Immunoendocrinology, pp 115-128, 2010, George S. Eisenbarth (ed.). Springer Verlag 2011.

Methlie P, Husebye ES, Hustad S, Lien EA, Løvås K. Grapefruit juice and liquorice increase cortisol availability in patients with Addison’s disease​
Eur J Endocrinol, 165, 761-9, 2011.

Brønstad I, Wolff AS, Lovas K, Knappskog PM, Husebye ES. Genome-wide copy number variation (CNV) in patients with autoimmune Addison's disease. ​
BMC Med Genet, 12, 111-115.

Skinningsrud B, Lie BA, Lavant E, Carlson JA, Erlich H, Akselsen HE, Gervin K, Wolff AB, Erichsen MM, Løvås K, Husebye ES*, Undlien DE*. Multiple loci in the HLA complex are associated with Addison’s disease.
J Clin Endocrinol Metabol, 96, E1703-8, 2011.

Nermoen I, Rørvik J, Holmedal SH, Hykkerud DL, Fougner KJ, Svartberg J, Husebye ES, Løvås K. High frequency of Adrenal Myelolipomas and Testicular Adrenal Rest Tumours in adult Norwegian Patients with Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. ​
Clin Endocrinol 75, 753-9, 2011.

Oftedal BEV, Kämpe O, Meager A, Ahlgren K, Lobell A, Husebye ES, Wolff ASB. 
Measuring autoantibodies against IL-17F and IL-22 by radioimmunoassay using fusion proteins. 
Scand J Immunol, 74, 327-333

Lima K, Abrahamsen TG, Wolff ASB, Husebye ES, Alimohammadi M, Kämpe O, Følling I.
Hypoparathyroidism and autoimmunity in the 22q11.2 deletion syndrome. ​
Eur J Endocrinol 165, 345-352, 2011.

Bratland E, Husebye ES. Cellular immunity and immunopathology in autoimmune Addison's disease 
Mol Cell Endocrinol 336, 180-190, 2011.

Smith CJ, Oscarson M, Rönnblom L, Alimohammadi M, Perheentupa J, Husebye ES, Gustafsson J, Nordmark G, Meloni A, Crock PA, Kämpe O, Bensing S. TSGA10 - A target for autoantibodies in autoimmune polyendocrine syndrome type 1 and systemiclupus erythematosus.
Scand J Immunol 73, 147-53, 2011

2010:

Erichsen MM, Husebye ES, Michelsen TM, Dahl AA, Løvås K. Sexuality and fertility in women with Addison's disease.                                                                                              J Clin Endocrinol Metab. 2010 Sep;95(9):4354-60. Epub 2010 Jul 7.

Nermoen I, Husebye ES, Svartberg J, Løvås K. Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway.      Eur J Endocrinol. 2010 Sep;163(3):453-9. Epub 2010 Jun 15.

Wolff AS, Oftedal BE, Kisand K, Ersvaer E, Lima K, Husebye ES. Flow cytometry study of blood cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type I.                                                                                    Scand J Immunol. 2010 Jun;71(6):459-67.

Sørheim JI, Husebye ES, Nedrebø BG, Svarstad E, Lind J, Boman H, Løvås K. Phenotypic variation in a large family with autosomal dominant hypocalcaemia.                       Horm Res Paediatr. 2010;74(6):399-405. Epub 2010 May 26.

Husebye ES, Anderson MS. Autoimmune polyendocrine syndromes: clues to type 1 diabetes pathogenesis.    ​                                                                                               Immunity. 2010 Apr 23;32(4):479-87. Review.PMID:20412758

Cheng MH, Fan U, Grewal N, Barnes M, Mehta A, Taylor S, Husebye ES, Murphy EJ, Anderson MS. Acquired autoimmune polyglandular syndrome, thymoma, and an AIRE defect.
N Engl J Med. 2010 Feb 25;362(8):764-6.

Kisand K, Bøe Wolff AS, Podkrajsek KT, Tserel L, Link M, Kisand KV, Ersvaer E, Perheentupa J, Erichsen MM, Bratanic N, Meloni A, Cetani F, Perniola R, Ergun-Longmire B, Maclaren N, Krohn KJ, Pura M, Schalke B, Ströbel P, Leite MI, Battelino T, Husebye ES, Peterson P, Willcox N, Meager A. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines.
J Exp Med. 2010 Feb 15;207(2):299-308. 

Løvås K, Curran S, Oksnes M, Husebye ES, Huppert FA, Chatterjee VK. Development of a disease-specific quality of life questionnaire in Addison's disease.
J Clin Endocrinol Metab. 2010 Feb;95(2):545-51. Epub 2009 Dec 16.

Erichsen MM, Husebye ES, Michelsen TM, Dahl AA, Løvås K. Sexuality and fertility in women with Addison's disease.​                                                                                              J Clin Endocrinol Metabol, 95, 4354-4360, 2010

Sørheim JI, Husebye ES,,Nedrebø BG,Svarstad E, Lind J, Boman H, Løvås K. 
Phenotypic variation in a large family with autosomal dominant hypocalcaemia.
Hormone research in pædiatrics 74, 399-405, 2010.

Wolff ASB, Oftedal BEV, Kisand K, Ersvær E, Lima K, Husebye ES. Flow cytometry study of cell subtypes reflects autoimmune and inflammatory processes in autoimmune polyendocrine syndrome type I.                                                                                    Scand J Immunol, 71, 459-467, 2010.

Husebye ES, Anderson MS. Autoimmune polyendocrine syndromes: clues to type 1 diabetes pathogenesis. ​
Immunity, 32, 479-487, 2010.

2009:

Husebye ES. Functional autoantibodies cause hypoparathyroidism.​
J Clin Endocrinol Metab. 2009 Dec;94(12):4655-7.  

Bratland E, Skinningsrud B, Undlien DE, Mozes E, Husebye ES. T cell responses to steroid cytochrome P450 21-hydroxylase in patients with autoimmune primary adrenal insufficiency.
J Clin Endocrinol Metab. 2009 Dec;94(12):5117-24.

Erichsen MM, Løvås K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J, Fougner KJ, Berg TJ, Bollerslev J, Mella B, Carlson JA, Erlich H, Husebye ES. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry.
J Clin Endocrinol Metab. 2009 Dec;94(12):4882-90.

Mitchell AL, Cordell HJ, Soemedi R, Owen K, Skinningsrud B, Wolff AB, Ericksen M, Undlien D, Husebye E, Pearce SH.
Programmed death ligand 1 (PD-L1) gene variants contribute to autoimmune Addison's disease and Graves' disease susceptibility.​
J Clin Endocrinol Metab. 2009 Dec;94(12):5139-45.  

Tóth B, Bøe Wolff AS, Halász Z, Tar A, Szüts P, Ilyés I, Erdős M, Szegedi G, Husebye ES, Zeher M, Maródi L. Novel sequence variation of AIRE and detection of interferon-omega antibodies in early infancy.​
Clin Endocrinol (Oxf). 2009 Oct 26. 

Skinningsrud B, Husebye ES, Gilfillan GD, Frengen E, Erichsen A, Gervin K, Ormerod E, Egeland T, Undlien DE. X-linked congenital adrenal hypoplasia with hypogonadotropic hypogonadism caused by an inversion disrupting a conserved noncoding element upstream of the NR0B1 (DAX1) gene.
J Clin Endocrinol Metab. 2009 Oct;94(10):4086-93.

Skinningsrud B, Lie BA, Husebye ES, Kvien TK, Førre O, Flatø B, Stormyr A, Joner G, Njølstad PR, Egeland T, Undlien DE. A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-CCP negative rheumatoid arthritis.​
Ann Rheum Dis. 2009 Sep 3. 

Bratland E, Bredholt G, Mellgren G, Knappskog PM, Mozes E, Husebye ES. The purification and application of biologically active recombinant steroid cytochrome P450 21-hydroxylase: the major autoantigen in autoimmune Addison's disease.​
J Autoimmun. 2009 Aug;33(1):58-67.

Husebye ES, Løvås K. Immunology of Addison's disease and premature ovarian failure.
Endocrinol Metab Clin North Am. 2009 Jun;38(2):389-405, 

Løvås K, Gjesdal CG, Christensen M, Wolff AB, Almås B, Svartberg J, Fougner KJ, Syversen U, Bollerslev J, Falch JA, Hunt PJ, Chatterjee VK, Husebye ES. Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone.
Eur J Endocrinol. 2009 Jun;160(6):993-1002. 

Husebye ES, Perheentupa J, Rautemaa R, Kämpe O. Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I.
J Intern Med. 2009 May;265(5):514-29.

Husebye E, Løvås K. Pathogenesis of primary adrenal insufficiency.
Best Pract Res Clin Endocrinol Metab. 2009 Apr;23(2):147-57.  

Alimohammadi M, Dubois N, Sköldberg F, Hallgren A, Tardivel I, Hedstrand H, Haavik J, Husebye ES, Gustafsson J, Rorsman F, Meloni A, Janson C, Vialettes B, Kajosaari M, Egner W, Sargur R, Pontén F, Amoura Z, Grimfeld A, De Luca F, Betterle C, Perheentupa J, Kämpe O, Carel JC. Pulmonary autoimmunity as a feature of autoimmune polyendocrine syndrome type 1 and identification of KCNRG as a bronchial autoantigen.
Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4396-401. 

Fetissov SO, Bensing S, Mulder J, Le Maitre E, Hulting AL, Harkany T, Ekwall O, Sköldberg F, Husebye ES, Perheentupa J, Rorsman F, Kämpe O, Hökfelt T. Autoantibodies in autoimmune polyglandular syndrome type I patients react with major brain neurotransmitter systems.
J Comp Neurol. 2009 Mar 1;513(1):1-20.

Erichsen MM, Løvås K, Fougner KJ, Svartberg J, Hauge ER, Bollerslev J, Berg JP, Mella B, Husebye ES. Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death.​
Eur J Endocrinol. 2009 Feb;160(2):233-7.  

Nermoen I, Følling I, Vegge K, Larmo A, Nedrebø BG, Husebye ES, Løvås K. Two adults with adrenal myelolipoma and 21-hydroxylase deficiency.
Case Report Med. 2009;2009:916891.

2008:

Skinningsrud B, Husebye ES, Gervin K, Løvås K, Blomhoff A, Wolff AB, Kemp EH, Egeland T & Undlien DE. Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease. ​
Eur J Hum Genet 2008;16: 977-982.

F Magitta N, Pura M, S Bøe Wolff A, Vanuga P, Meager A, M Knappskog P, Husebye ES. Autoimmune polyendocrine syndrome type I in Slovakia: relevance of screening patients with autoimmune Addison's disease. 
Eur J Endocrinol 2008; 158 (5):705-9

Kisand K, Link M, Wolff AS, Meager A, Tserel L, Org T, Murumägi A, Uibo R, Willcox N, Trebusak Podkrajsek K, Battelino T, Lobell A, Kämpe O, Lima K, Meloni A, Ergun-Longmire B, Maclaren NK, Perheentupa J, Krohn KJ, Scott HS, Husebye ES, Peterson P. Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes. ​                                                                                                     Blood. 2008 Oct 1;112(7):2657-66.

Meloni A, Furcas M, Cetani F, Marcocci C, Falorni A, Perniola R, Pura M, Bøe Wolff AS, Husebye ES, Lilic D, Ryan KR, Gennery AR, Cant AJ, Abinun M, Spickett GP, Arkwright PD, Denning D, Costigan C, Dominguez M, McConnell V, Willcox N, Meager. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I. 
J Clin Endocrinol Metab. 2008 Nov; 93 (11): 4389-97

Oftedal BE, Wolff AS, Bratland E, Kämpe O, Perheentupa J, Myhre AG, Meager A, Purushothaman R, Ten S, Husebye ES. Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I. 
Clin Immunol. 2008 Oct; 129 (1); 163-9.         

Bøe Wolff AS, Oftedal B, Johansson S, Bruland O, Løvås K, Meager A, Pedersen C, Husebye ES & Knappskog PM. AIRE variations in Addison's disease and autoimmune polyendocrine syndromes (APS): partial gene deletions contribute to APS I. 
Genes Immun 2008;9: 130-136.

Magitta NF, Bøe Wolff AS, Johansson S, Skinningsrud B, Lie BA, Myhr KM, Undlien DE,Joner G, Njølstad PR, Kvien TK, Førre O, Knappskog PM, Husebye. A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. ​
Genes Immun. 2008 Oct 23

Skinningsrud B, Husebye ES, Pearce SH, McDonald DO, Brandal K, Bøe Wolff A, Løvås K, Egeland T & Undlien DE. Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency.                                                                      J Clin Endocrinol Metab 2008 Eur J Hum Genet. 2008 Aug;16(8):977-82.

Løvås K, Husebye ES. Replacement therapy for Addison's disease: recent developments.
Expert Opin Investig Drugs. 2008 Apr;17(4):497-509.

Bøe Wolff AS, Oftedal B, Johansson S, Bruland O, Løvås K, Meager A,Pedersen C, Husebye ES,Knappskog PM. AIRE variations in Addison's disease and autoimmune polyendocrine syndromes (APS): partial gene deletions contribute to APS I.
Genes Immun. 2008 Mar;9(2):130-6. Epub 2008 Jan 17.

Alimohammadi M, Björklund P, Hallgren A, Pöntynen N, Szinnai G, Shikama N, Keller MP,Ekwall O, Kinkel SA, Husebye ES, Gustafsson J, Rorsman F, Peltonen L, Beterle C, Perheentupa J, Akerström G, Westin G, Scott HS, Holländer GA, Kämpe O. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.​
N Engl J Med. 2008 Mar 6;358(10):1018-28.

Husebye ES. Endocrinologic emergency medicine.​
Tidsskr Nor Laegeforen. 2008 Feb 28;128(5):574.

Skinningsrud B, Husebye ES, Gervin K, Løvås K, Blomhoff A, Wolff AB, Kemp EH, Egeland T & Undlien DE. Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease.​                                                                                             Eur J Hum Genet 2008;16: 977-982.

2007:

Løvås K, Husebye ES. Continuous subcutaneous hydrocortisone infusion in Addison's disease.
Eur J Endocrinol. 2007 Jul;157(1):109-12.

Wolff AS, Myhr KM,Vedeler CA, Husebye ES. Fc-gamma receptor polymorphisms are not associated with autoimmune Addison's disease.​
Scand J Immunol. 2007 Jun;65(6):555-8.                                                                                 
Sandaker PS, Husebye ES, Fondenes O, Bindoff LA. Clinical evolution of Kearns-Sayre syndrome with polyendocrinopathy and respiratory failure.
Acta Neurol Scand Suppl. 2007;187:64-7.

Løvas K, Husebye ES. Salivary cortisol in adrenal disesases.​
Tidsskr. Nor Lægeforen. 2007 Mar 15;127(6):730-2. Review Norwegian.

Bensing S,Fetissov SO,Mulder J, Perheentupa J, Gustafsson J, Husebye ES, Oscarson M. Ekwall O, Crock PA,Hokfelt T, Hulting AK, Kampe O. Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1.
Proc Natl Acad Sci USA 2007 Jan 16;104(3);949-54. Epub 2007 Jan 10.

Bratland E, Wollf AS, Haavik J, Kampe O, Skoldberg F,Perheentpa J, Bredholt G, Knappskog PM,Husebye ES. Epitope mapping of human aromatic L-amino acid decarboxylase. 
Biochem Biophys Res Commun, 2007 Feb 16;353(3):692-8.Epub 2006 Dec 22.

Wolff AS,Erichsen MM,Meager A, Magitta NF,Myhre AG,Bollerslev J, Fougner K,Lima K, Knappskog PM, Husebye ES. Autoimmune polyendocrine syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. 
J Clin. Endocrinol Metab. 2007 Feb;92(2):595-603.Epub 2006 Nov 21.

2006:

Husebye ES, Bredholt G, Fridkin M, Dayan M, Zinger H, Mozes E. Identification of an immunodominant T cell epitope in 21-hydroxylase, the main autoantigen in autoimmune Addison's disease.
Endocrinology, 147, 2411-6, 2006.

Meager A, Visvalingam KV, Peterson P, Möll K, Murumåagi A, Krohn K, Eskelin P, Perheentupa J, Husebye ES, Kadota Y, Willcox N. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. 
Plos Med Jul,3(7)3, e289.

Bredholt G Storstein A, Haugen M, Krossnes B, Husebye ES, Knappskog PM, Vedeler CA. Detection of autoantibodies to the BTB-kelch protein KLHL7 in cancer sera. 
Scandinavian J of Immunol,  2006 64 (3):325-35.

Løvås K, Thorsen T, Husebye ES. Saliva cortisol measurement: Simple and reliable assessment of the glucocorticoid replacement therapy in Addison's disease. ​
J Endocrinol Invest, 2006 Sep,29(8):727-31.

Husebye ES,Bratland E, Bredholt G, Fridkin M, Dayan M, Mozes E. The substrate-binding domain of 21-hydroxylase,the main autoantigen in autoimmune Addisons's disease, is an immunodominant T cell epitope.                                            Endocrinology. 2006 May;147(5):2411-6.Epub 2006 Feb 23.

2005:

Husebye ES, Varhaug JE, Heimdal K. Hereditary endocrine tumour diseases.
Tidsskr Nor Lægeforen. 2005 Nov 3;125(21):2964-7.

Lovas K,Husebye ES. Addison's disease.
Lancet. 2005 Jun 11-17;365(9476):2058-61

Lovas K,Erichsen MM,Husebye ES,Fougner KJ,Svartberg J, Mella B, Myhre AG,Berg JP, Aarskog D. Primary adrenal failure-causes, diagnostics and therapy.
Tidsskr. Nor Lægeforen.2005 Jan 20;125(2):155-8 .

Blomhoff A,Kemp EH,Gawkrodger DJ, Weetman AP, Husebye ES,Akselsen HE,Lie AB,Undlien DE. CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases. 
Pigment Cell Res.18,55-8,2005.​

2004:

Bøe AS,Bredholt G,Knappskog PM,Hjelmervik TO,Winquist O,Kämpe O,Husebye ES. Autoantibodies against 21-hydroxylase and side-chain cleavage enzyme in autoimmune Addison's disease are mainly immunoglobulin G1.
Eur J Endocrinol. 150,49-56,2004

Söderbergh A,Myhre AG,Mietinen A,Eskelin P,Ekwall O, Halonen M,Hedstrand H,Nilsson T,Landgren E,Tuomi T,Gustafsson J,Husebye ES,Perheentupa J, Manns MP,Kämpe O,Rorsman F. Prevalence and Clinical Associations of Ten Defined Autoantibodies in Autoimmune Polyendocrine Syndromes Type 1. 
J Clin Endocrinol Metabo 89,557-62,2004.

Storstein A,Monstad SE,Nakkestad Hl,Husebye ES,Vedeler CA. Paraneoplastic antibodies detected by a sensitive radiobinding assay.
J Neurology,251,197-203,2004.

Kvistad PH, Lovas K, Boman H, Myking OL. Retarded bone growth in thyroid hormone resistance. A clininal study of a large family with a novel thyroid hormone receptor mutation.​
Eur J Endocrinol.2004 Apr;150(4):425-30

Sköldberg F,Rorsman F,Perheentupe J,Landin-Olson M, Husebye ES,Gustafsson J,Kämpe O. Analysis of antibody reactivity against cysteine sulfinic acid decarboxylase, a pyridoxal phosphate dependent enzyme, in endocrine autoimmune disease.​
J Clin Endocrinol Metabol, 89,1636-40,2004.

Blomhoff A, Lie BA, Myhre AG, Kemp EH, Weetman AP, Akselsen HE, Husebye ES, Undlien DE. Polymorphisms in the CTLA4 gene region confer susceptibility to Addison's disease. 
J Clin Endocrinol Metabol, 89, 3474-3476, 2004.

Myhre AG, Stray-Pedersen A, Spangen S, Eide E, Veimo D, Knappskog PM, Abrahamsen TG, Husebye ES. Chronic mucocutaneous candidiasis and primary hypothyroidism in two families. 
Eur J Pediatr, 163, 604-611, 2004.

2003:

Løvås K, Gebre-Medhin G,Trovik T,Fougner K,Uhlving S, Nedrebø BG, Myking OL,Kämpe O,Husebye ES. Replacement of dehydroepiandrosterone in adrenal failure.No benefit for subjective health status in a placebo-controled clinical trial.          J Clin Endocrinical Metabol,88,1112-1118,2003

Sköldberg F,Portela-Gomes GM,Grimelius L,Nilsson G,Perheentupa J,BetterleC,Husebye ES,Gustafsson J,Rønnblom A,Rorsman F,Kämpe O. Histidine Decarboxylase, a pyridoxal phosphate-dependent enzyme, is an autoantigen of gastric enterochromaffin-like cells.
J Clin Endocrinol Metabol,88,1445-1452,2003.

Løvås K,Husebye ES,Holsten F, Bjorvatn B. Sleep disturbances in patients with Addison's disease.​ 
Eur J Endocrinol 148,449-456,2003

Myhre AG,Årsethøy H,Undlien DE,Hovdenak N,Aksnes L,Husebye ES. High frequency of coeliac disease among patients with autoimmune adrenocortical failure.
Scand J Gastroenterol,38, 511-515, 2003.

2002:

Myhre AG, Undlien DE, Løvås K, Uhlving S, Nedrebø, BG, Fougner K, Trovik T, Sørheim JI, Husebye ES. Autoimmune adrenocortical failure in Norway. Autoantibodies and HLA class II associations related to clinical features.​
J Clin Endocrinol Metabol, 87, 618-623, 2002.

Nedrebø BG,Holm P,Ulving S, Sørheim JI, Skeie S, Eide GE, Husbye ES,Lien EA, Aanderud S. Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Gra​ves' disease. 
Eur J Endocrinol, 147,583-589.2002.

Bøe AS, Knappskog PM, Myhre AG, Sørheim JI, Husebye ES. Mutational analysis of the autoimmune regulator gene (AIRE) in sporadic autoimmune Addison`s Disease can reveal patients with unidentified autoimmune polyendocrine syndrome type I. 
Eur J Endocrinol, 146, 519-522, 2002.

Løvås K, Loge JH, Husebye ES. Subjective Health Status in Norwegian patients with Addison's disease. 
Clin Endocrinol, in press, 56, 581-588, 2002.

Nesje LB,Varhaug JE,Husebye ES, Ødegaard S. Endoscopic ultrasongraphy for preoperative diagnosis and localization of insulinomas.                                                     Scand J Gastroenterolo,37,732-737,2002

Halonen M, Eskelin P, Myhre AG, Perheentupa J, Husebye ES, Kämpe O, Rorsman F, Peltonen L, Partanen J. AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype.
J Clin Endokrinol Metabol,87 2568-2574,2002

 Myhre AG, Undlien DE, Løvås K, Uhlving S, Nedrebø, BG, Fougner K, Trovik T, Sørheim JI, Husebye ES. Autoimmune adrenocortical failure in Norway. Autoantibodies and HLA class II associations related to clinical features. ​
J Clin Endocrinol Metabol, 87, 618-623, 2002

2001:

Myhre AG, Halonen M, Ekwall O, Eskelin P, Hedstrand HH, Kämpe O, Rorsman F, Husebye ES. Autoimmune polyendocrine  syndrome type 1 (APS I) in Norway. ​
Clinical Endocrinology 54, 211-217, 2001.

Hedstrand H, Ekwall O, Olsson MJ, Landgren E, Kemp EH, Weetman AP, Perheentupa J, Husebye ES, Gustafsson J, Betterle C, Kämpe O, and Rorsman R. The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I. 
J Biol Chem, 276, 35390-35395, 2001.

Astuti D, Latif F, Dallol A, Dahia A, Douglas F, George E, Sköldberg F, Husebye ES, Eng C,  Maher ER. Mutations in the mitochondrial complex II subunit SDHB cause susceptibility to familial pheochromocytoma and paraganglioma. 
Am J Hum Genetics, 69, 49-54, 2001.

2000:

Hedstrand H, Ekwall O, Haavik J, Landgren E, Betterle C, Perheentupa J, Gustafsson J, Husebye E, Rorsman F, Kampe O. Identification of tyrosine hydroxylase as an autoantigen in autoimmune polyendocrine syndrome type I.
Biochem Biophys Res Commun, 267, 456-61, 2000.

Gebre-Medhin, Husebye ES, Mallmin H, Helström L, Berne C, Karlsson FA, Kämpe O. Oral dehydroepiandrosterone (DHEA) replacement therapy in women with Addison's disease. ​
Clin Endocrinol, 52, 775-780, 2000.

Husebye ES, Bøe A, Rorsman F, Kämpe O, Aakvaag A, Rygh T, Flatmark T, Haavik J. Inhibition of aromatic l-amino acid decarboxylase activity by human autoantibodies. 
Clin Exp Immunology 120, 420-423, 2000.

Ekwall O, Hedstrand HH, Haavik J, Perheentupa J, Betterle C, Gustafsson J, Husebye ES, Kämpe O, Rorsman F. Pteridin dependent hydroxylases as autoantigens in autoimmune polyendocrine syndrome type I. 
J Clin Endocrinol Metabol, 85, 2944-2950, 2000.

Søderbergh A, Rorsman F, Björses P, Ekwall O, Rygh T, Kämpe O and Husebye ES. Autoantibodies against aromatic L-amino acid decarboxylase delineate a subgroup of patients with Addison's disease.
J Clin Endocrinol Metabol 85, 460-463, 2000.

1999:

Hedstrand H, Peerhentupa J, Ekwall E, Gustafson J, Nordlind K, Michaëlsson G, Husebye ES, Frosman F, Kämpe O. Antibodies against hair follicles are associated with alopecia totalis in patients with autoimmune polyendocrine syndrome type I. 
J Invest Dermatol 113, 1054-8, 1999.

1998:

Ekwall O, Hedstrand HH, Grimelius L, Haavik J, Perheentupa J, Gustafsson J, Husebye ES, Kämpe O, Rorsman F. Identification of tryptophan hydroxylase as an intestinal autoantigen. The Lancet, 352, 279-283, 1998

Kemp E, Ajjan RA, Husebye ES, Peterson P, Uibo, R, Imrie H, Pearce S, Watson PF, Weetman AP. A cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism is associated with autoimmune Addison's disease in English patients.​ 
Clin Endocrinol, 49, 609-614, 1998.

Myhre A-G, Bjørses P, Dalen A, Husebye ES. Three sisters with Addison's disease.
J Clin Endocrinol Metabol, 83, 4204-4206, 1998.

1997:

Husebye ES, Gebre-Medhin G, Tuomi T, Perheentupa J, Landin-Olsson M, Gustafsson J, Rorsman F and Kämpe O. Autoantibodies against Aromatic L-amino acid Decarboxylase in Autoimmune Polyendocrine Syndrome Type I.                                       J Clin Endocrinol Metabol, 82, 147-150, 1997. 

Oversiktsartikler:

 

Bensing S, Hulting AL, Husebye ES, Kämpe O, Løvås K. MANAGEMENT OF ENDOCRINE DISEASE: Epidemiology, Quality of Life and Complications of Primary Adrenal Insufficiency: a review. Eur J Endocrinol.175, R107-116, 2016.

Simunkova K, Husebye ES. Adrenal Insufficiency Therapy: How to Keep the Balance between Good Quality of Life and Low Risk for Long-Term Side Effects. Front Horm Res. 46, 196-210, 2016.

 

Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, Husebye ES, Merke DP, Murad MH, Stratakis CA, Torpy DJ. Diagnosis and treatment of primary adrenal insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metabol 101, 364-389, 201

Husebye ES, Allolio B, Arlt W, Badenhoop K, Bensing S, Betterle C, Falorni A, Gan EH, Hulting AL, Kasperlik-Zaluska A, Kämpe O, Løvås K, Meyer G, Pearce SH. Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. ​J Intern Med. 2014 Feb;275(2):104-15. doi: 10.1111/joim.12162. Epub 2013 Dec 16. Review.

Løvås K, Erichsen MM, Husebye ES, Fougner KJ, Svartberg J, Mella B, Myhre AG, Berg JP, Aarskog D. Primær binyrebarksvikt-årsaker, diagnostikk og behandling. Tidsskr Nor lægeforen,125,155-8,2005.

Husebye, ES, Varhaug JE, Heimdal K. Arvelige nevroendokrine tumorer.​ Tidsskr Nor Laegeforen. In press, 2005.

Løvås K, Cooper JG, Thorsen T, Thordarson H, Husebye ES. Døgnrytme til besvær. Tidsskr Nor lægeforen, 123, 1858-1859, 2003.

Løvås K, Husebye ES. Replacement therapy in Addison's disease.​ Curr Opinion Pharmacotherapy 4, 2145-2149, 2003.

Husebye ES. Cushing syndrom. I Livsboka, En bok om Addison, Adrenogenitalt Syndrom, Akromegali Cushing og hypofysesvikt. Morbus Addison foreningen 2003, pp 49-56.

Husebye ES. Akutt binyrebarksvikt, symptomer og behandling. Tidsskr Nor Lægeforen, 121,1260, 2001.

Husebye ES, Aanderud S. Primær binyrebarksvikt - en diagnostisk utfordring. Tidsskr Nor Lægefor, 118, 542-544, 1998.

Husebye ES. Autoimmune polyendokrine syndrom. Pediatrisk endokrinologi,11, 40-44, 1998.​​

 
 






Fann du det du leita etter?
Tilbakemeldinga vil ikkje bli svart på. Ikkje send personleg informasjon, for eksempel e-post, telefonnummer eller personnummer.